Oldgren J, Laurila S, Akerblom A, Latva-Rasku A, et al. Effects of 6 weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study. Diabetes Obes Metab 2021 Feb 24. doi: 10.1111/dom.14363.
PMID: 33625777